5-ethynyl-2--deoxyuridine and Shock--Septic

In clinical laboratories, the evaluation of lymphocyte proliferative response (lymphocyte transformation test-LTT) is routinely performed by the measurement of [(3)H]-thymidine uptake after stimulation. In this study we evaluated the performances of a recently developed non-radioactive test based on the detection by flow cytometry of 5-ethynyl-2'deoxyuridine (EdU) incorporation for the measurement of LTT in routine lab conditions. After definition of optimal protocol parameters, EdU incorporation test showed good repeatability and reproducibility. Moreover, this assay was flexible enough to fit important clinical laboratory constraints (delayed stimulation, low number of cells and delayed analysis after staining). Importantly, correlations between results obtained with EdU and [(3)H]-thymidine incorporation assays were excellent both in healthy volunteers and pediatric and septic patients. In particular, the two techniques identified patients presenting with altered LTT. Upon confirmation in a larger cohort of patients, EdU incorporation assay may be a relevant non-radioactive candidate for LLT in clinic.

Topics: Antibodies, Monoclonal; Biological Transport; Case-Control Studies; Cell Proliferation; Deoxyuridine; Flow Cytometry; Fluorescent Dyes; Humans; Lymphocyte Activation; Lymphocytes; Phycocyanin; Phytohemagglutinins; Primary Cell Culture; Reproducibility of Results; Shock, Septic; Thymidine; Tritium